newsfilter
← Latest News
PR Newswire·

Volition Announces Data to Support Use of Nu.Q® NETs in New Indication

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the release of a new clinical study...